A physiological role for endocannabinoid-derived products of cyclooxygenase-2-mediated oxidative metabolism

British Journal of Pharmacology

Volumn 153, Issue 7, 2008, Pages 1341-1343

  Guindon, J ^a   Hohmann, A G ^a  

^a University of Georgia ^*  (United States)

Author keywords

2 arachidonoylglycerol; Anandamide; Cyclooxygenase; Cytochrome P450; Endocannabinoid; Lipoxygenase; Monoacylglycerol lipase; Nociception; Peripheral; Prostaglandin

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ACETYLSALICYLIC ACID; ANANDAMIDE; ARACHIDONIC ACID; CARRAGEENAN; CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; CYCLOOXYGENASE 2; ENDOCANNABINOID; IBUPROFEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROSTAGLANDIN E2; PROSTAGLANDIN E2 GLYCEROL ESTER; UNCLASSIFIED DRUG;

AEROBIC METABOLISM; HYPERALGESIA; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MECHANICAL STIMULATION; NOTE; PAIN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; ARACHIDONIC ACIDS; CYCLOOXYGENASE 2; DINOPROSTONE; GLYCERIDES; HOMEOSTASIS; HUMANS; OXIDATION-REDUCTION; SIGNAL TRANSDUCTION;

EID: 41649099056     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/bjp.2008.41     Document Type: Note

References (10)

1. Dirig DM, Isakson PC, Yaksh TL (1998). Effect of COX-1 and COX-2 inhibition on induction and maintenance of carrageenan-evoked thermal hyperalgesia in rats. J Pharmacol Exp Ther 285: 1031-1038.
2. Fowler CJ (2007). The contribution of cyclooxygenase-2 to endocannabinoid metabolism and action. Br J Pharmacol 152: 594-601.
3. Hu SSJ, Bradshaw HB, Chen JSC, Tan B, Walker JM (2008). Prostaglandin E2 glycerol ester, an endogenous COX-2 metabolite of 2-arachidonoylglycerol that produces hyperalgesia and modulates NFκB activity. Br J Pharmacol 153: 1538-1549 (this issue).
4. Kozak KR, Gupta RA, Moody JS, Ji C, Boeglin WE, DuBois RN et al. (2002). 15-Lipoxygenase metabolism of 2-arachidonylglycerol: generation of a peroxisome proliferator-activated receptor alpha agonist. J Biol Chem 277: 23278-23286.
5. Kozak KR, Marnett LJ (2002). Oxidative metabolism of endocannabinoids. Prostaglandins Leukot Essent Fatty Acids 66: 211-220.
6. Kozak KR, Prusakiewicz JJ, Rowlinson SW, Prudhomme DR, Marnett LJ (2003). Amino acid determinants in cyclooxygenase-2 oxygenation of the endocannabinoid anandamide. Biochemistry 42: 9041-9049.
7. Piomelli D (2005). The endocannabinoid system: a drug discovery perspective. Curr Opin Investig Drugs 6: 672-679.
8. Snider NT, Kornilov AM, Kent UM, Hollenberg PF (2007). Anandamide metabolism by human liver and kidney microsomal cytochrome P450 enzymes to form hydroxyeicosatetraenoic and epoxyeicosatrienoic acid ethanolamides. J Pharmacol Exp Ther 321: 590-597.
9. Ueda N, Yamamoto K, Yamamoto S, Tokunaga T, Shirakawa E, Shinkai H et al. (1995). Lipoxygenase-catalyzed oxygenation of arachidonylethanolamide, a cannabinoid receptor agonist. Biochim Biophys Acta 1254: 127-134.
10. 2 ethanolamide from anandamide by cyclooxygenase-2. J Biol Chem 272: 21181-21186.